---
title: "RARE.US (RARE.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/RARE.US/news.md"
symbol: "RARE.US"
name: "RARE.US"
parent: "https://longbridge.com/en/quote/RARE.US.md"
datetime: "2026-05-20T16:19:23.111Z"
locales:
  - [en](https://longbridge.com/en/quote/RARE.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/RARE.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/RARE.US/news.md)
---

# RARE.US (RARE.US) — Related News

### [Ultragenyx Shareholders Approve Incentive Plan, Elect Directors](https://longbridge.com/en/news/286809118.md)
*2026-05-18T18:53:35.000Z*
> Ultragenyx Pharmaceutical shareholders approved the 2023 Incentive Plan and elected Class I directors at the Annual Meet

### [HC Wainwright Brokers Decrease Earnings Estimates for RARE](https://longbridge.com/en/news/286097226.md)
*2026-05-12T12:14:32.000Z*
> HC Wainwright has revised its Q1 2027 earnings estimate for Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) from $0.28 to $

### [Ultragenyx Pharmaceutical (RARE) Gets a Buy from Piper Sandler](https://longbridge.com/en/news/285537982.md)
*2026-05-07T11:14:06.000Z*
> Piper Sandler analyst Allison Bratzel has maintained a Buy rating on Ultragenyx Pharmaceutical (RARE) with a price targe

### [Universal Beteiligungs und Servicegesellschaft mbH Has $323,000 Position in Ultragenyx Pharmaceutical Inc. $RARE](https://longbridge.com/en/news/285372807.md)
*2026-05-06T12:00:41.000Z*
> Universal Beteiligungs und Servicegesellschaft mbH reduced its stake in Ultragenyx Pharmaceutical Inc. by 84.6% in Q4, h

### [Ultragenyx Pharma | 8-K: FY2026 Q1 Revenue Misses Estimate at USD 136 M](https://longbridge.com/en/news/285258429.md)
*2026-05-05T20:13:39.000Z*
### [Ultragenyx CFO’s Latest Stock Move Has Investors Buzzing](https://longbridge.com/en/news/285146405.md)
*2026-05-05T02:07:33.000Z*
> Ultragenyx Pharmaceutical's CFO, Howard Horn, sold 4,683 shares valued at $116,606 on May 4, 2026, attracting investor a

### [Ultragenyx Pharmaceutical (NASDAQ:RARE) Upgraded to Hold at Wall Street Zen](https://longbridge.com/en/news/284984174.md)
*2026-05-03T05:06:53.000Z*
> Wall Street Zen upgraded Ultragenyx Pharmaceutical (NASDAQ:RARE) from a "sell" to a "hold" rating. Other analysts have m

### [Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | RARE Stock News](https://longbridge.com/en/news/284052827.md)
*2026-04-24T12:30:00.000Z*
> Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) announced the grant of 36,447 restricted stock units to 12 newly hired non